© 1990 Oxford University Press
other |
Investigations on the origin of tobacco-specific nitrosamines n mainstream smoke of cigarettes
Institute for Toxicology and Chemotherapy, German Cancer Research Center Im Neuenheimer Feld 280, 6900 Heidelberg, FRG
The origin of tobacco-specific nitrosamines (TSNA) in mainstream smoke and the possible contribution of synthesis during the smoking procedure was investigated. Addition of the nitrosamine precursors nitrate and nicotine to the tobacco prior to smoking did not change the mainstream smoke concentrations of N'-nitrosonornicotine (NNN) and 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), whereas the mainstream smoke concentration of N'-nitrosoanabasine (NAB) and N'-nitrosoanatabine (NAT) Increased after spiking the cigarettes with nitrate. Data for TSNA in tobacco and in mainstream smoke and for nitrate in tobacco of commercial cigarettes of the West German market, taken from previous investigations, were used to calculate the mainstream smoke/tobacco ratios for NNN and NNK. These ratios were corrected for ventilation and cigarette length. it is shown that the ratios are constant and neither depend on the nicotine level nor on the nitrate level of the tobacco except for NNK in the nitrate rich dark tobacco type cigarettes. For nonfilter cigarettes the transfer rates of NNN and NNK which had been corrected for ventilation and cigarette length amounted to 23 or 34% respectively. For filter cigarettes a transfer rate of 13% for NNN and 23% for NNK was calculated. Furthermore it is shown that the mainstream smoke/tobacco ratios for NNN and NNK are constant over the whole length of the cigarettes except for NNK in dark tobacco type cigarettes. The results of this investigation indicate that pyrosynthesis of NNN does not occur and that it is very unlikely for NNK at least for lower nitrate levels. Thus with few exceptions the TSNA burden of smokers is predominantly influenced by the amount of preformed NNN and NNK in tobacco.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. S. Maritz Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring Therapeutic Advances in Respiratory Disease, August 1, 2009; 3(4): 193 - 210. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. S. Ding, L. Zhang, R. B. Jain, N. Jain, R. Y. Wang, D. L. Ashley, and C. H. Watson Levels of Tobacco-Specific Nitrosamines and Polycyclic Aromatic Hydrocarbons in Mainstream Smoke from Different Tobacco Varieties Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3366 - 3371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R J O'Connor and P J Hurley Existing technologies to reduce specific toxicant emissions in cigarette smoke Tob. Control, September 1, 2008; 17(Suppl_1): i39 - i48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Stepanov, P. Upadhyaya, S. G. Carmella, R. Feuer, J. Jensen, D. K. Hatsukami, and S. S. Hecht Extensive Metabolic Activation of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Smokers Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1764 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Alam, M. J. Conway, H.-S. Chen, and C. Meyers The Cigarette Smoke Carcinogen Benzo[a]pyrene Enhances Human Papillomavirus Synthesis J. Virol., January 15, 2008; 82(2): 1053 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Mirvish Reducing Carcinogen Levels in Cigarette Smoke Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2170 - 2170. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. N. Ye, E. S. L. Liu, V. Y. Shin, W. K. K. Wu, and C. H. Cho The Modulating Role of Nuclear Factor-{kappa}B in the Action of {alpha}7-Nicotinic Acetylcholine Receptor and Cross-Talk between 5-Lipoxygenase and Cyclooxygenase-2 in Colon Cancer Growth Induced by 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 123 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Gray and P Boyle The case of the disappearing nitrosamines: a potentially global phenomenon Tob. Control, March 1, 2004; 13(1): 13 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Fowles and E Dybing Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke Tob. Control, December 1, 2003; 12(4): 424 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Schuller, P. K. Tithof, M. Williams, and H. Plummer III The Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Is a {beta}-Adrenergic Agonist and Stimulates DNA Synthesis in Lung Adenocarcinoma via {beta}-Adrenergic Receptor-mediated Release of Arachidonic Acid Cancer Res., September 1, 1999; 59(18): 4510 - 4515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Mitacek, K. D. Brunnemann, D. Hoffmann, T. Limsila, M. Suttajit, N. Martin, and L. S. Caplan Volatile nitrosamines and tobacco-specific nitrosamines in the smoke of Thai cigarettes: a risk factor for lung cancer and a suspected risk factor for liver cancer in Thailand Carcinogenesis, January 1, 1999; 20(1): 133 - 137. [Abstract] [Full Text] [PDF]
|
|